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 Cellular signaling is a tightly regulated process which defines how cells interact 
with their environment and maintain homeostasis. It is also the mechanism by which they 
change. Neuronal development is one such process that depends on the concerted 
activities of many molecular signaling pathways to proceed through highly typified 
stages. A neuron’s morphology is a perfect example of spatially distinct compartments 
which change over time. The spatial and temporal regulation of signaling pathways 
within the dendrites, soma, and axon during development require second messengers and 
kinases for proper establishment of neuronal morphology. The second messenger 3'-5'-
cyclic adenosine monophosphate (cAMP) and kinase cAMP-dependent protein kinase 
(PKA) are considered critical axon determinants; meaning without them the axon does 
not form. At the second messenger level, cAMP is generated by adenylyl cyclase and 
degraded by phosphodiesterases in the cellular milieu to balance the cAMP concentration 
in specific signaling microdomains. When activated by cAMP, PKA phosphorylates its 
substrates which can be both upstream and downstream of itself. But the cAMP/PKA 
signaling pathway components are not randomly strewn throughout the cell. Instead, they 
are bound and tightly regulated within a signaling platform called the A-kinase anchoring 
protein (AKAP) signalosome. AKAPs bring PKA into close proximity to its substrates, 
source of cAMP, and scaffold other signaling partners to produce profound effects on a 
neuron’s fate. To understand how cAMP and PKA control neuronal polarization in living 
neurons, we utilized fluorescence resonance energy transfer (FRET)-based biosensors 
shed light on their activities in different regions and at different stages of development. 
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 This dissertation is composed of four chapters: an introduction, the major project, 
a minor project, and concluding remarks. The first chapter introduces major concepts and 
information regarding cyclic nucleotide signaling, cyclic nucleotide effectors, signal 
compartmentalization and methods used to visualize molecular activity in living cells. 
The second chapter contains the bulk of the thesis work in which we investigated the role 
of spatiotemporally compartmentalized cAMP and PKA signaling in developing neurons. 
Here, we used the FRET-based cAMP reporter ICUE3 and PKA reporter AKAR4 to 
study how their molecular activities differ between the spatially distinct soma, dendrites, 
and axons of developing hippocampal neurons. In this study we have demonstrated how 
gradients of cAMP and PKA in the axon are regulated by phosphodiesterase activity and 
scaffolding by AKAPs. We also show the functional significance of AKAP anchoring in 
neuronal development by analyzing axon outgrowth. Lastly, we link the functional 
outcomes to the gradients of molecular activity and developed a conceptual model for our 
observations. In the third chapter, we describe and characterize a new suite of targeted 
cGMP biosensors to help further the understanding of cGMP compartmentalization. In 
the fourth and last chapter, we provide a review of the thesis work and provide some 
perspective on future directions.   
 As a whole, the studies presented here demonstrate how cAMP, PKA, and cGMP 
signaling within the spatially distinct compartments of living cells is regulated. The 
gradients alluded to in the literature over the years are now revealed using the spotlight of 
genetically encoded FRET-based biosensors. Furthermore, we present the field of 
neurodevelopment with a new target of study, the AKAPs, which we show have 
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Cyclic Nucleotide Signaling: An Overview 
The simplest unit of life is the cell. In complex multicellular organisms, many cells 
are organized together, as they are in specialized tissues, in order to keep the organism 
alive and functioning. A key component to life is the ability for cells and tissues to respond 
to changes in the external environment. Through a series of biochemical events called 
signal transduction pathways, or signaling cascades, cells transmit signals from a stimulus 
and convert it to a specific cellular response. Many signal transduction cascades are 
facilitated by cell surface receptor activation, which converts a signal into the production 
of many second messenger molecules. The second messengers then activate many 
downstream target effector molecules to continue the signaling cascade. In this way, 
signals are transduced and amplified by the activation of cellular machinery. An ancient 
and ubiquitous second messenger signaling pathway is comprised of the cyclic nucleotides 
cyclic 3’, 5’ adenosine monophosphate (cAMP) and cyclic 3’, 5’ guanosine 
monophosphate (cGMP) found in both prokaryotic and eukaryotic cells. Cyclic nucleotides 
are key players in important cellular functions like including homeostasis, cell division, 
and cell differentiation. The cyclic nucleotides act by binding and activating various targets 
that are immediately downstream of the second messenger. The major targets for cAMP, 
protein kinase A (PKA) and exchange protein directly activated by cAMP (Epac), mediate 
critical physiological functions like cardiac cell contractility, insulin secretion, nerve cell 
action potentials, and nerve cell axon growth. cGMP activates protein kinase G (PKG) to 
mediate smooth muscle relaxation, phototransduction in the retina, and nerve cell dendrite 
growth. This following sections and chapters of this thesis will focus on the role and 
regulation of cyclic nucleotides and their effectors with emphasis on their activity in the 




Indeed, the role of cAMP and cGMP in the nervous system is wide and varied. 
Importantly, the foundation for proper nervous system function is the proper formation of 
structures in both the central and peripheral nervous system. When a nerve stem cell makes 
the transition from a pre-mitotic to a post-mitotic cell, neuronal differentiation is initiated. 
Given that cyclic nucleotide signaling plays a critical part in neuronal differentiation, it is 
important to understand the molecular mechanisms regulating the dynamics of cyclic 
nucleotides at the single cell level. 
 
An overview of cAMP and cGMP signaling 
cAMP and cGMP are ubiquitous second messengers present in most cell types. 
Within the brain, cyclic nucleotides transduce neuromodulatory signals into functional 
outputs for individual neurons leading to changes in neural networks themselves or their 
function. The importance of cyclic nucleotide signaling pathways is well appreciated in the 
field of clinical neuroscience and psychiatry, with many drugs targeting the G-protein 
coupled receptors (GPCRs) to modulate neuronal activity2, 3. The effects of cAMP and 
cGMP signaling range from regulating neuronal differentiation and growth to axonal 
guidance and modulation of neuronal excitability. To accomplish this, cyclic nucleotides 
are coupled to many downstream effectors4. cAMP, the prototypical cyclic nucleotide, 
transduces G-protein signals to activate PKA and Epac. cGMP, on the other hand, relays 
signals from nitric oxide to activate PKG. Phosphodiesterase (PDE), the enzyme that 
degrades cyclic nucleotides, can also be an effector with its activity modulated by cyclic 
nucleotide binding to regulatory domains forming feedback loops5. Both cyclic nucleotides 





cAMP signaling  
cAMP was discovered by Nobel Prize winner (1971) Earl Sutherland and T. W. 
Rall in the 1950’s while studying the effect of epinephrine and other molecules on liver 
extracts7. The canonical cAMP signaling pathway relies on the activation of a 
transmembrane Gαs-coupled GPCR by binding of an extracellular agonist such as a 
hormone or a neurotransmitter (Fig. 1.1a)8. A change in conformation of the receptor leads 
to the release of the bound Gαs subunit from Gβγ on the intracellular side of the plasma 
membrane. Gαs binds to transmembrane adenylyl cyclase (tmAC), the enzyme responsible 
for converting ATP to cAMP9, 10. At the AC activation step, the signal is amplified through 
the generation of many cAMP molecules. Activation of soluble adenylyl cyclases (sAC), 
a diffusible protein found in discrete subcellular compartments, by bicarbonate and calcium 
is another route of cAMP generation11, 12. cAMP produced by either tmAC or sAC can bind 
to various effectors that include PKA, Epac, and ion channels to continue the signaling 








II PKA uses RII subunits. Four R subunit isoforms (RIα, RIβ, RIIα, & RIIβ) and three C 
subunit isoforms (Cα, Cβ, and Cγ) have been discovered with each isoform having specific 
biological functions and cellular expression profiles16, 17. The regulatory subunits contain 
a cyclic nucleotide binding domain (CNBD), which is a common feature of cyclic 
nucleotide effectors. Prior to binding cAMP, the regulatory subunits tightly bind and inhibit 
the catalytic subunits. Each regulatory subunit can cooperatively bind two molecules of 
cAMP with low nanomolar affinity, inducing a conformational change that releases the 
catalytic subunits to phosphorylate many PKA substrates on serine and threonine 
residues15, 16. For optimal catalytic activity, PKA requires phosphorylation of the active site 
residue Thr197 by the phosphoinositide dependent kinase (PDK1) or PDK1-like kinase18-
20. PKA specificity is achieved by active site recognition of substrates that share a 
phosphorylation consensus motif (R-R-X-S/T-Φ, where Φ represents a hydrophobic 
residue), as well as the spatiotemporal compartmentalization of the kinase and its upstream 
modulators34. PKA activity is antagonized by phosphatases that dephosphorylate PKA 
substrates21. With the help of spatiotemporal compartmentalization, PKA converts the 
cAMP signal into many different functional outputs that are important for critical 
biological functions such as the metabolism of glycogen22, 23, lipids24, and steroids25, gene 
regulation26, 27, cell growth28, proliferation29, and differentiation30, 31, synaptic plasticity32-
34, and ion channel conductivity35.   
 
Epac activation and signaling 
The second major effector of cAMP is known as Epac was discovered by de Rooij 




explained why certain effects of cAMP could not be attributed to PKA or cyclic nucleotide-
gated ion channels37. The Epac family is comprised of two identified isoforms, Epac1 and 
Epac2, which are guanine nucleotide exchange (GEF) factors that exchange GDP for GTP 
on the GTPase Rap138. While Epac1 and Epac2 are variably expressed in different tissues 
and have differing roles, they do have a common structure that includes a regulatory CNBD 
and catalytic domain39. Epac1 contains a single cAMP binding site, while Epac2 contains 
two40, 41. Prior to activation, the catalytic domain is sterically hindered by the regulatory in 
auto-inhibitory fashion. Once cAMP is bound, the Epac undergoes a conformational 
change reorienting the enzyme into an active conformation. The net effect of cAMP 
signaling therefore includes the activation of PKA, Epac, and other effectors that may act 
independently42, synergistically43, or opposite44 of each other to carry out and amplify the 
cAMP signal. Prior to the discovery of Epac, it was thought that the sole enzymatic effector 
of cAMP in neurons was PKA. Several years of research has now revealed that Epac1 plays 




The story of cGMP began with its synthesis in 1961 by Smith, Drummon, and 
Khorana49, and it was later discovered in rat urine in 1963 50. The cGMP signaling pathway 
is initiated when nitric oxide synthase (NOS) is activated by calcium-calmodulin and 
converts the amino acid L-arginine to nitric oxide (NO)51, 52 (Fig. 1.1b). NO transduces the 
signal to soluble guanylyl cyclase (sGC), which produces cGMP from GTP53. The 





The idea of compartmentalized signaling is an essential component to the cyclic 
nucleotide signaling model. To elicit their diverse functional effects in a highly specific 
manner, cAMP and cGMP signaling is spatially compartmentalized and temporally 
regulated57. The levels of cyclic nucleotides and the activities of downstream effectors are 
not uniform throughout the cell, but instead form specific nanodomains or microdomains 
inside the cell. The spatial compartmentation is partially achieved by strict regulation of 
cyclic nucleotide production and degradation. At the level of production, ACs and GCs are 
found at different locations within the cell, and are activated by different mechanisms. 
PDEs have been shown to function as cAMP and cGMP sinks to help maintain these 
microdomains58, 59. The tight spatiotemporal regulation of cAMP is achieved with the help 
of the A-kinase anchoring protein60, which assembles signaling complexes consisting of 
members of the cAMP/PKA signaling pathway like ACs, PDEs, PKA and its substrate, 
and other effectors. These signalosomes, which can be found throughout various 
compartments including the plasma membrane, the cytosol and the nucleus, have been 
shown to play important roles in achieving functional specificity of the cAMP/PKA 
pathway. In addition to biochemical regulation, the structural properties of cells can also 
affect the signaling dynamics of second messengers 61, 62 
 
Adenylyl and Guanylyl Cyclases 
Mammalian cAMP production mediated by Gαs activation can occur through any 
one of the nine separate genes for tmAC designated producing the AC proteins designated 
as ACI through ACIX63. Differential tissue expression and modulation of the AC isoforms 




specifically expressed in a neuro-specific fashion64. On one hand, both ACI and ACIII are 
maximally stimulated by coincidental binding of Gαs and Ca2+-calmodulin, which links 
cAMP to voltage dependent changes in neuronal signaling.  On the other hand, ACV and 
ACVI are inhibited by Ca2+ and are the major AC isoforms expressed in mammalian 
cardiac tissue for regulating cardiac contraction65. As already mentioned, sAC, activated 
by bicarbonate and calcium, is other source of cAMP in the cell and can be found in the 
bulk cytosol as well as in discrete locations like the nucleus.  
The localization of sGC in neurons is one way that mediators of neuronal 
polarization can fulfill their functions. Often times, the localization of a downstream 
signaling component can spatially define the cellular response to an upstream signaling 
component. Such is the case with sGC and Sema3A in cortical neurons. Research on the 
role of Sema3a in neuronal polarity identified concentrated localizations of sGC in apical 
dendrites both in vitro and in vivo66. They further showed that sGC is not responsible for 
mediating the growth responses of Sema3a but rather orienting the growth of apical 
dendrites through its asymmetric localization in developing cortical neurons.  
 
Phosphodiesterases 
Both cAMP and cGMP are spatiotemporally regulated by the enzymatic activity of 
PDEs. PDEs shut down signaling by binding the cyclic nucleotides and carrying out a 
hydrolysis reaction of the phosphodiester bond to generate a nucleoside monophosphate. 
By degrading cyclic nucleotides, PDEs control the location, magnitude, and duration of 
cyclic nucleotide signaling in the cell67, 68. Without this regulation, cyclic nucleotides 




activate various effectors. There are 11 PDE families that have varying affinities for the 
cyclic nucleotides. PDE1-3, PDE10, and PDE11 degrade both cAMP and cGMP. PDE4, 
PDE7, and PDE8 specifically degrade cAMP, whereas PDE5, PDE6, and PDE9 
specifically degrade cGMP. Each PDE family has multiple isozymes with varying tissue 
and cell-type expression and intracellular localization. PDEs themselves are spatially 
controlled by scaffolding proteins described in the next section. Tissue expression and 
intracellular localization confers specificity to PDE function leading to different biological 
outcomes. For example, PDE3 and PDE4 within subcellular microdomains of the 
sarcoplasmic reticulum have been implicated in cardiomyocyte function69. Studies in 
neurons identified PDE4D as a major regulator of cAMP gradients during the process of 
neuronal polarization70. The localization of PDEs helps generate different “pools” of 
cAMP to activate different effectors further enhancing signaling specificity. PDE signaling 
dynamics are made more complex by the presence of post-translational modifications like 
phosphorylation and ubiquitinylation, protein-protein interactions, and binding of other 
molecules like calcium71, 72. Finally, it is important to note that as with many of the cAMP 
signaling enzymes, more than one isoform of PDEs are often found in different cell types, 
adding to the complexity of cAMP and cGMP signal regulation.  
 
A-kinase anchoring proteins 
 One way to achieve compartmentalization of a signaling pathway is to spatially 
restrict protein localization and generate signaling microdomains. The cAMP/PKA 
signaling pathway is under the spatiotemporal regulation of the A-kinase anchoring protein 




are characterized by three defining features73. First, they all bind PKA regulatory subunits. 
Second, they bind PKA substrates as well as other components involved in shaping the 
signaling response downstream of cAMP. Third, AKAPs themselves contain targeting 
motifs to localize to different subcellular compartments.  
To spatially restrict PKA activity, AKAPs bind to PKA R subunit dimers in their 
hydrophobic pocket called the dimerization domain (D/D) using an α-helical stretch of 14 
to 18 amino acids74.  The RII-specific AKAPs are most abundant in cells, but AKAPs can 
bind either type I or type II PKA holoenzymes or both. The identity of the hydrophobic 
amino acids within the α-helix confer varying degrees of affinity for the RII subunit within 
the low nanomolar range. The RI subunit has a high nanomolar to low micromolar affinity 
for AKAPs that can be attributed to an N-terminal 12 amino acid shift in the D/D, which 
may hinder RI-AKAP interactions75. The lower affinity may also be explained by the 
compact structure PKA RI dimers, while PKA RII dimers are more extended 76.  
In addition to PKA, the AKAPs also tether many other proteins including ACs77, 
PDEs78, phosphatases79, other kinases like PKC or ERK80, Epac81, ion channels82, and 
cytoskeletal elements83 using similar α-helical binding domains. AKAPs regulate the 
specificity of PKA phosphorylation by bringing PKA substrates into close proximity to the 
kinase. By binding ACs and PDEs, AKAPs also control the temporal dynamics of 
compartmentalized cAMP production and degradation.  
Further compartmentalization is achieved by the localization of AKAPs discrete 
subcellular compartments with the help of special targeting motifs84, 85. AKAPs can be 
found in multiple locations throughout the cell including the plasma membrane, organelle 





Cyclic Nucleotide Signaling in Neuronal Polarization 
 The study of neuronal polarization began 40 years ago in the 1970s and 1980s when 
observations of differences between dendrites and axons were first made by pioneering 
neurodevelopment scientists like Gary Banker and others88. The axons and dendrites are 
spatially distinct neuronal compartments that allow neurons to communicate with one 
another. Neuronal stimulation induces the generation of an action potential that travels 
down the axon to synapses between that axon and dendrites of another cell. But before 
mature neurons are electrically active in such a way, they must first establish their identity 
through polarization. This process is fundamental to the growth of the central nervous 
system and the generation of the complex neural circuitry. In vitro cultures of hippocampal 
neurons were studied to understand how these cells achieve their elaborate forms. 
Researchers were able to show that there are breaks in the uniform symmetry of dissociated 
neurons, followed by extension of small filopodia, rapid growth of the future axon, and 
further elaboration of the future dendrites89-92. Since that time, many different signaling 
mechanisms have been found to affect the polarization and differentiation of neurons both 
in vitro and in vivo. Not surprisingly, cAMP and cGMP play essential roles for axon and 
dendrite development, respectively.  
  
cAMP/PKA and Epac in neuronal morphogenesis 
Neurotrophins are molecules that promote the growth and development of neurons. 
Typically released into the extracellular space, they bind to neurotrophin receptors and 
initiate signal transduction cascades that positively affect neuronal function. Brain-derived 




neurotrophic factors that have been discovered. As mentioned in preceding sections, cAMP 
activates PKA and Epac to control cellular responses. Over the past decade, cAMP 
activation of both PKA and Epac engage signaling mechanisms that can control axon 
initiation and outgrowth. During the polarization process, research has found that cAMP 
stimulated PKA leads to the phosphorylation of Liver Kinase B1 and its accumulation in a 
single undifferentiated neurite to designate it as the future axon93, 94.  BDNF and 
cAMP/PKA have been shown to participate in a localized positive feedback loop at axon 
growth cones to promote axon elongation95. Other work has shown that cAMP participates 
in long-range signal inhibition, where cAMP elevation in one neurite can decrease cAMP 
in the other neurites providing a mechanism for the generation of a single axon and multiple 
dendrites70.  
 Recent years have produced new insights into axon growth signaling mechanisms, 
and Epac is now fully appreciated as a player in axon growth and guidance decisions that 
are distinct from those of PKA96. For example, using Epac specific cAMP-analogs, 
research found that PC12 cells undergo the switch from proliferation to differentiation and 
neurite outgrowth using cAMP activation of Epac46. The direct target of Epac GEF activity 
is the GTPase Rap1, a molecule whose localization to the tip of a growing neurite results 
in axon specification. In one study, pharmacological inhibition or knockdown of Epac1 
reduced the growth of hippocampal neurons in vitro47. Another study used a 
photoactivatable adenylyl cyclase (PAC) to optically control cAMP levels and found Epac 
regulated axon elongation with higher concentrations of cAMP, while PKA regulated axon 




cAMP signaling network and indicate that the spatiotemporal regulation of cAMP plays 
important roles in axonal morphogenesis.  
  
cGMP in dendrite specification 
 While cAMP is important for axon growth, cGMP influences the development of 
dendrites by mediating the signal from Semaphorin3A (Sema3a). Semaphorins are a highly 
varied family of secreted and membrane-bound signaling molecules critical for nervous 
system development98. Sema3a is recognized as a chemorepellent axon guidance 
molecule99 and a chemoattractant for dendrites66. By coupling to the neuropilin receptor, 
Sema3a decreases cAMP, increases cGMP, and promotes dendrite formation in developing 
neurons. Although the exact mechanism has not been identified, sGC activation has been 
seen in Xenopus neurons treated with Sema3a. Another mechanism by which cGMP 
induces dendrite specification was found in Xenopus spinal commissural interneurons. 
Voltage gated calcium Cav2.3 channels localized to and specified future dendrites when 
cells were treated with Sema3a, which elevated cGMP100. This study linked cGMP/PKG 
to Cav2.3 expression and localization, and the specification of dendrites both in vitro and 
in vivo. These and other data demonstrate Sema3a mediated cGMP signaling pathways 
help to establish dendrite identity in developing neuronal systems.  
 
Methods to Study Signal Transduction Pathways 
Relatively recent advances in fluorescent biosensor technology allow researchers 
to track the dynamics of cyclic nucleotides and their effectors in living neurons and brain 




nucleotide dynamics have been developed with advances in molecular and cell biology. 
These sensors have been implemented living cells, including neurons, for the purpose of 
understanding how cyclic nucleotides impact neuronal function and development.  
An overview of fluorescence 
Fluorescence microscopy is a cornerstone of modern biological investigation from 
the nanoscale to the whole organism level. Fluorescent protein (FP) technology 
revolutionized the field of cell and developmental biology by providing a genetically 
encodable fluorescent tag. Prior to the cloning of A. victoria GFP, cellular imaging 
required the preparation and microinjection of macromolecules conjugated with 
fluorescent dyes. Genetic encodability relieved researchers from the cumbersome protocols 
of labeling macromolecules by letting the cells do the work. Given the fact that the FP 
primary amino acid sequence contains all the information needed for fluorescence, there is 
tremendous versatility in the use of FPs to precisely monitor the signaling dynamics of 
living cells. In addition, the ability to add a specific subcellular localization sequence to a 
fusion construct increases the spatial resolution to “sub-microscopic” levels.101 Extensive 
studies involving fluorescent fusion proteins have proven that FPs do not, in most cases, 
affect a protein’s function or movement.  
Fluorescent proteins, including green fluorescent protein from A. victoria  (GFP) 
and dsRed, have chromophores buried within their tertiary structures that can absorb and 
emit light.102 The chromophore is produced autocatalytically in an aerobic environment 
through a process known as maturation. Generally, an 11-stranded β-barrel makes up the 
tertiary structure that protects the chromophore from the solvent. The specific 




contributes to the different spectral properties exhibited by different fluorophores.  
There are dozens of enhanced FPs to choose from with different properties including the 
excitation and emission spectra, fluorescence lifetime, extinction coefficient, quantum 
yield, photostability and maturation speed.103 The seven major variants of FPs are divided 
by their emission maxima as follows: blue (BFP 440-470 nm), cyan (CFP; 471-500 nm), 
green (GFP; 501-520 nm), yellow (YFP; 521-550 nm), orange (OFP; 551-575 nm), red 
(RFP; 576-610 nm), and far-red RFP (FRFP; 611-660 nm). It is important to choose the 
appropriate fluorescent protein for your desired application. 
 
Genetically encodable fluorescent protein based biosensors 
Genetically encoded fluorescent biosensors allow for the continuous monitoring of 
free cyclic nucleotide concentrations with high spatiotemporal resolution. These biosensors 
are engineered based on a general design: a sensing unit to detect the change in free cyclic 
nucleotide concentration and a reporting unit to convert the biochemical change into a 
fluorescent readout. The sensing unit for cyclic nucleotides biosensors is one or more cyclic 
nucleotide binding domains (CNBD). The reporting unit can be made up of two fluorescent 
proteins flanking the sensing unit as is the typical arrangement for fluorescence resonance 
energy transfer (FRET)-based biosensors. In FRET, energy is transferred non-radiatively, 
from an excited donor molecule to an acceptor molecule. For a fixed FRET donor-acceptor 
pair, the efficiency of FRET is dependent on the distance and orientation of the two 
fluorophores. In a FRET-based biosensor, cyclic nucleotide binding induces 
conformational changes of the CNBD sensing unit acting as a molecular switch to change 




change in FRET (Fig. 1.3A). In intensity-based biosensors, on the other hand, the reporting 
unit can be a single fluorescent protein. In this case, conformational changes in the sensing 
unit are translated into changes in fluorescence intensity (Fig. 1.3B). Different sensors vary 
in their CNBD sensing units and fluorescent protein reporting units. For a thorough 
overview of fluorescence and fluorescent proteins used in many different types of 





fluorescent protein-based biosensor. The sensing unit transduces a signal via a 
conformational change to the linked fluorescent protein reporting unit that undergoes its 
own conformational change and modulates fluorescence intensity. A circularly permuted 
GFP is often used to enhance the change in fluorescence. (C) ICUE3 consists of an 
Epac1149-881 sensing unit flanked by an ECFP donor and a cpV-L194 acceptor reporting 
unit. Upon binding cAMP, the sensor switches from a high FRET to a low FRET 
conformation. (D) cGES-DE5 consists of a GAF-A sensing unit derived from PDE5A 
flanked by an ECFP donor and EYFP acceptor reporting unit. Upon binding cGMP, the 
sensor switches from a low FRET to a high FRET conformation. (E) AKAR4 contains a 
sensing unit consisting of a FHA1 phosphoamino acid binding domain and a substrate 
peptide. The reporting unit is comprised of a Cerulean donor and cpV-E172 acceptor 
reporting unit. When PKA activity is high, the substrate peptide is phosphorylated and 
binds the FHA1 domain to induce FRET. (F) δ-FlincG utilizes a PKG1α77-356 sensing unit 
linked to a single cpGFP reporting unit. Upon binding cGMP, the fluorescence intensity of 
cpGFP increases.  
 
A history of the Indicator of cAMP Using Epac  
For the purposes of tracking cAMP, researchers have been developing molecular 
biosensors for the past several decades. For example, bimolecular PKA subunit-based 
probes, unimolecular Epac1 and Epac2-camps based on Epac CNBDs, and HCN2-camps  
based on the cAMP gated potassium channel HCN2, are different cAMP sensors that have 
been developed. Here, we would like to focus on a series of Epac based reporters called 
ICUE (Indicator of cAMP Using Epac) that have been developed as powerful and versatile 
cAMP sensors for live-cell imaging. First in the series, ICUE1 contained full-length Epac1 
sandwiched between ECFP and the YFP variant Citrine105. Like Epac1-camps and Epac2-
camps, ICUE also responds to cAMP with a decrease in the yellow to cyan emission ratio. 
ICUE2, an improved version of ICUE1, has an EC50 of ~12.5 µM and contains a N-
terminally truncated Epac1 protein (Epac1149-881)106. This biosensor showed improvement 
in localization over ICUE1 due to removal of a membrane and mitochondria targeting 




dynamic range by changing the FRET acceptor Citrine to a circularly permuted Venus at 
lysine 194 (cpV-L194)107 (Fig. 1.3C). The large dynamic range of ICUE3 (~100% emission 
ratio change) makes it suitable for subcellular targeting for detecting local cAMP changes 
(e.g. plasma membrane and nucleus108, sarcoplasmic reticulum109, primary cilia110) as 
addition of subcellular localization tags sometimes leads to decreased response amplitudes. 
 
A history of the A-Kinase Activity Reporter 
Neuromodulatory signals can be transduced by cAMP and cGMP through their 
downstream target kinases PKA and PKG, respectively 111. Although there are no 
biosensors yet available for PKG activity, the A-kinase activity reporter (AKAR) can report 
on the kinase activity of PKA 101. AKAR uses a molecular switch consisting of a 
phosphoamino acid binding domain linked to a PKA-specific substrate sequence flanked 
by CFP and YFP. PKA phosphorylation of its substrate induces binding of the 
phosphorylated substrate to the phosphoamino acid binding domain, leading to an increase 
in FRET. AKAR1 displayed an irreversible FRET response, which prevented continuous 
monitoring of PKA dynamics. This was presumably due to the high affinity of the 14-3-3 
binding domain for the substrate as tight binding may prevent phosphatases from 
dephosphorylating the substrate and reversing the FRET response.  This was overcome by 
the generation of AKAR2 that utilized the lower binding affinity forkhead-associated 
domain 1 (FHA1) and exhibited a reversible FRET response 112. The kinetics of AKAR2 
were improved in AKAR2.2 by replacing the dimeric forms of ECFP and Citrine with 
versions that resist dimerization. The dynamic range was doubled in AKAR3 by replacing 




enhanced with latest version, AKAR4, by replacing ECFP with Cerulean 114 (Fig. 1.3E). 
Due to the amplification of the cAMP signal by PKA phosphorylation activity, PKA 
activity reporters may be able to detect signals not picked up by cAMP binding probes. 
Recently, a modified AKAR probe named AqAKARCit, was generated by replacing 
Cerulean with Aquamarine, a newly engineered CFP variant that has mutations T65S and 
H148G 115. These modifications to ECFP increased its photophysical properties and 
reduced its environmental sensitivity to low pH. 
 
A history of the cGMP Energy Transfer Sensor Derived from PDE5A 
Like cAMP, cGMP has had the attention of groups specialized in biosensor 
development to effectively monitor cGMP in living cells. Some examples include the 
Cygnet probes116, cGES-GKIB117 and the cGi series based on tandem CNBDs from 
PKG1α. The cGMP probe cGES-DE5 was developed by Nikolaev et al. in order to monitor 
cGMP levels inside living cells.117 The acronym stands for cGMP energy transfer sensor 
derived from PDE5A. The sensing unit of cGES-DE5 is the regulatory GAF-A domain 
from PDE5A and the reporting unit is comprised of EYFP at the N-terminus and ECFP at 
the C-terminus (Fig. 1.3D). The regulatory GAF-A domain from PDE5A binds cGMP and 
undergoes a conformational change, bringing the two FPs close together and facilitating 
FRET (Fig. 1.3D).118, 119 In conjunction with this probe, the authors developed a similar 
sensor based on PDE2 and PKGIB, but found cGES-DE5 to be the best with high 
selectivity for cGMP/cAMP and a large FRET response. This single-chain cGMP probe 
generates a 40% increase in emission ratio, representing a two-fold improvement over the 





Utilizing cyclic nucleotide biosensors to study neuronal differentiation 
 As mentioned previously, cAMP and cGMP are involved in many biological 
processes. As an example of utilizing cGES-DE5A to solve a biological problem, a study 
by Shelly et al. used ICUE3 and cGESDE5 to study neuronal development.70 cAMP is a 
well-known determinant of axonal polarization, whereas cGMP has been implicated in 
dendrite differentiation.120, 121 The authors conducted several experiments using primary 
rat cortical and hippocampal neurons transfected with ICUE3 or cGES-DE5. Exposing a 
neurite tip to cAMP agonists using glass beads caused a cAMP increase in the exposed 
neurite and a decrease in the other neurites. The same stimulation caused a decrease in 
cGMP in the stimulated neurite, and an increase in the distal neurites. This phenomenon 
was dubbed long range inhibition of cAMP. The authors argue for a mechanism of 
axon/dendrite polarization that involves localized increases of cAMP and cGMP and 
activation of their downstream effectors. Thus, ICUE3 and cGES-DE5A were used 
together to study the impact of reciprocal regulation of cyclic nucleotides in the developing 
nervous system. The ability of these genetically encoded biosensors to report free cyclic 
nucleotide dynamics in living cells with high spatial and temporal resolution makes them 
a very powerful tool for understanding the molecular mechanisms underlying critical 
biological processes.  
 
Advantages and limitations of FRET-based biosensors 




specific, and provide a snapshot of the biochemical state of a population of cells. However, 
these assays require many cells, lack spatial information and measure total levels of cyclic 
nucleotides. Early studies on cyclic nucleotide compartmentation comes from the use of 
cyclic nucleotide gated ion channels, but these were limited by single compartment 
localization and lack of generalizability122.  
FP based biosensors have many advantages over traditional biochemical techniques 
including their ability to: 1) measure free cyclic nucleotides in live cells, 2) provide 
information on temporal dynamics, 3) provide information on spatially compartmentalized 
nucleotides, 4) report on the cyclic nucleotide status of single cells, and 5) provide a 
quantitative ratiometric readout. Because these biosensors are genetically encodable, they 
are produced by the cell and can be continuously monitored in live cells to track cyclic 
nucleotide dynamics. By attaching subcellular targeting sequences to the N- or C- termini 
of the biosensor, it can report on dynamics within specific compartments or microdomains. 
Furthermore, genetically encoded biosensors help uncover the complexities of subcellular 
signaling events at the level of individual cells. This information generates insights into 
single cell behaviors and reveals variations between cells.  
The ability to provide a quantitative measurement of intracellular cyclic nucleotides 
is an attractive feature of ratiometric biosensors like ICUE3 and cGES-DE5A. By using 
the ratio of acceptor emission over donor emission upon donor excitation, some 
experimental variations such as light source and cell thickness are minimized making it 
possible to use calibration curves to help determine nucleotide concentration. This can be 
accomplished by obtaining lysate from a cell expressing a biosensor and adding known 




The FRET ratio can then be correlated to the concentration of free cyclic nucleotide in live 
cells123 In addition, single chain FRET biosensors do not have the problem of unequal 
donor-acceptor expression.  Taken together, the many advantages offered by genetically 
encoded biosensors for cyclic nucleotides make them a great option for researchers wishing 
to study real-time cyclic nucleotide signaling.  
 Every technology has limitations that need to be kept in mind when using the 
technology to answer biological questions. In the case of genetically encoded cyclic 
nucleotide biosensors, endogenous signaling pathways may be impacted by the 
introduction of a cyclic nucleotide biosensor. Due to the high affinity of CNBDs for their 
cyclic nucleotides, overexpressing them may buffer cAMP or cGMP, leaving the cell 
without enough cyclic nucleotide to complete the signaling process. Therefore, one needs 
to assess any perturbations to cell by comparing cyclic nucleotide dependent signal 
transduction responses between cells transfected with a biosensor versus a control GFP. 
Because every FRET reporter has a set dynamic range and cyclic nucleotide sensitivity, 
the level of cyclic nucleotide may not be faithfully reported. For example, the FRET change 
might plateau while the concentration of cyclic nucleotide is still increasing. This limitation 
can be addressed by designing sensors with varying sensitivities to cAMP and cGMP. If a 
particular signaling phenomenon induces small changes in cAMP for example, a biosensor 
with a high sensitivity should be able to detect it. This same biosensor may not be suitable 
however, for larger increases that saturate it early on during generation of cAMP. 
Therefore, a biosensor with a less sensitive FRET response would be more appropriate. To 
this extent, Russwurm et al. have developed a series of FRET sensors for cGMP based on 




numbers refer to the EC50 values for cGMP.124 Lastly, cyclic nucleotide specificity must 
be high in order to accurately report on cyclic nucleotide levels. Some domains bind to 
other cyclic nucleotides in addition to the target, making it difficult to study signaling in 





The second messengers cAMP and cGMP transduce many neuromodulatory 
signals from hormones and neurotransmitters into specific functional outputs. Their 
production, degradation and signaling are spatiotemporally regulated to achieve high 
specificity in signal transduction. The development of genetically encodable fluorescent 
biosensors has provided researchers with useful tools to study these versatile second 
messengers and their downstream effectors with unparalleled spatial and temporal 
resolution in cultured cells, tissues, and living animals. 
Although there has been significant progress made in understanding how the 
specific signaling of cyclic nucleotide second messengers is achieved, the mechanistic 
details in complex cell types like neurons are only just beginning to surface. Current and 
future fluorescent protein reporters will be essential to elucidate the role of cyclic 



















AKAP-mediated feedback control of cAMP gradients in 
developing hippocampal neurons 
 





















Neuronal development is an intricate, multi-stage process92 in which the transition 
from progenitor cell to fully developed neuron depends on spatiotemporally regulated 
signaling events. Polarized growth is a particularly crucial aspect of this process, with 
individual neurons relying on coordinated pathways to ensure the proper development of a 
spatially distinct axon and dendrites125. Among these, 3’5’ cyclic adenosine 
monophosphate (cAMP) signaling, a pathway that is essential for many neuronal 
functions33, is known to be a critical axon determinant98.  
cAMP is generated by adenylyl cyclases (ACs) and degraded by 
phosphodiesterases (PDEs); the free cAMP concentration in the cell is therefore dictated 
by the balance of these enzymatic activities. cAMP then binds and activates effector 
proteins such as protein kinase A (PKA) and exchange protein activated by cAMP (Epac), 
which play crucial roles in developing axons. For example, BDNF has been shown to 
elevate cAMP/PKA activity in the axon, leading to additional BDNF release and increased 
plasma membrane insertion of the BDNF receptor, TrkB, resulting in continued 
cAMP/PKA signaling and effectively generating a nested positive feedback loop in the 
nascent axon95. Similarly, Epac activation was shown to result in increased growth cone 
turning and neurite outgrowth, as well as axon regeneration in DRG neurons48. In 
hippocampal neurons, Epac regulates axon elongation via the activation of Rap1B and the 
subsequent activation of PI3K47. PKA and Epac have also been shown to play opposing 
roles. For example, in embryonic DRG neurons, growth cone attraction to morphogens was 




cAMP signaling specificity is often achieved by confining cAMP elevations to 
discrete subcellular compartments114, 126. For example, asymmetric cAMP signaling can 
directly influence the formation of a single axon and multiple dendrites. Specifically, 
axonal cAMP elevations were found to have long-range inhibitory effects on dendritic 
cAMP levels in hippocampal neurons (HNs), with the local elevation of cAMP at a nascent 
neurite leading to decreased cAMP levels in the remaining neurites70. 
Compartmentalization of the cAMP signaling machinery itself61, 127 can further refine the 
spatial control of cAMP dynamics to modulate cell physiology. Adenylyl cyclase 5 (AC5), 
for example, was previously shown to be enriched in the distal axon and growth cone128. 
Nevertheless, cAMP dynamics have not been systematically examined in 
subcompartments of developing neurons. 
At the PKA level, spatial compartmentalization is directly controlled by A-kinase 
anchoring proteins (AKAPs)60, 129, 130, with many different AKAPs acting as scaffolds for 
the PKA holoenzyme, adenylyl cyclases, phosphodiesterases, phosphatases, and ion 
channels131. The AKAP microdomain localizes the regulators and effectors of PKA 
signaling and serves to spatially control PKA function by binding the RII subunit of 
PKA132, the major regulatory subunit in neurons133. Thus, any PKA signaling that 
contributes to the initiation of morphological compartmentation exists within a scaffold of 
PKA regulators and effectors134. However, despite efforts to understand the role of AKAPs 
in neuronal excitability and synaptic responses33, 131, there has not been significant inquiry 
into the role AKAPs play in neuronal development. 
Here, we utilized genetically encoded fluorescence resonance energy transfer 




stage-four primary rat HNs135. Neurons at these stages have nascent and spatially distinct 
dendrites and axons in the process of elongation. Using these probes, we uncovered a 
developmentally timed, axon-directed cAMP gradient that is maintained by AKAP-
anchored PKA activity and that is critical for ensuring proper axonal development. Our 
results suggest that, although cAMP and PKA are widely regarded as playing a positive 
role in promoting and establishing neuronal polarity, axon elongation, and guidance31, 45, 
128, 136, 137, these signaling molecules in fact play a more nuanced role in shaping neuronal 
development than previously appreciated. 
 
Results 
Comparing spatial cAMP signaling in hippocampal neurons at different developmental 
stages  
As first demonstrated by the pioneering work of Dotti et al.92, 138, the stages of 
neuronal development can be defined in vitro by plating HNs onto polylysine-coated glass 
coverslips. Between the time of plating and 7 days in culture, neurons proceed through five 
main stages of growth. At stage one (0 h), the neuron is uniform in shape, with small, 
lamellar protrusions extending from the cell body. At stage two (12 h), the neuron forms 
immature neurites. At stage three (36 h), the cell begins to specify the fate of one of these 
neurites to grow rapidly and form the axon. At stage four (4 days), the dendrites begin to 
grow. At stage five and beyond (>7 days), the neuron begins to mature. We therefore used 
rat (Rattus norvegicus) HNs grown for five days in vitro (DIV5) to investigate the 





We first used the genetically encoded FRET-based cAMP biosensor ICUE3 (Fig. 
2.1a)107 to analyze the activity and regulation of cAMP in living neurons. ICUE3 contains 
a truncated version of Epac1 (aa 149-881) sandwiched between ECFP (donor) and 
cpVenus-L194 (acceptor), wherein the binding of cAMP results in a conformational 
change in this truncated Epac1 and an increase in the donor-to-acceptor (C/Y) emission 
ratio. Using this probe, we observed a range of emission ratio changes in different regions 
of DIV5 HNs upon bath stimulation with 50 µM forskolin (Fsk), a general activator of 
transmembrane ACs; on average, the ratio increases were significantly lower in the soma, 
dendrites, and proximal axon (21.8±3.7%, 24.5±3.7%, and 30.6±5.0%, respectively) than 
in the middle and distal axon (41.8±5.3% and 47.8±5.7%; mean±SEM, n=12) (Fig. 2.1b-
d), indicating the presence of a gradient of cAMP signaling towards the axon in these cells. 
These data are consistent with previously suggested axonal-dendritic differences in 







Although axonal-dendritic differences in cAMP have previously been suggested to 
assist in neuronal development70, 95, cAMP gradients have yet to be investigated at different 
stages of development. We therefore compared the cAMP dynamics of DIV5 HNs with 
those of less-developed DIV3 HNs. Overall, we observed a weaker and more uniform 
ICUE3 response to Fsk stimulation in DIV3 cells compared with that in DIV5 cells, with 
a gradual increase of ~15% over 20 min and no significant differences in the different 
cellular regions (Fig. 2.1f-h). Thus, neurons at different developmental stages have 
different capacities for generating cAMP gradients. 
Because such capacities originate from balanced actions of ACs and PDEs139, we 
next tested the role of PDEs in generating the cAMP gradient observed in DIV5 cells. 
Interestingly, treatment with the general PDE inhibitor 3-isobutyl 1-methylxanthine 
(IBMX) revealed a weak axon-directed cAMP response in these cells (Fig 2.2a), with 
subsequent Fsk stimulation producing a large, uniform ratio increase of ~50-60% (Fig. 
2.1e). DIV3 HNs treated with IBMX similarly exhibited a small, axon-directed increase in 
cAMP (Fig 2.2b), followed by a larger, uniform increase in emission ratio upon Fsk 
stimulation (Fig. 2.1i). Treatment with the isoform-specific inhibitors rolipram (PDE4 
specific) and milrinone (PDE3 specific) followed by Fsk revealed that PDE4 is the 
dominant isoform at DIV3, as well as at DIV5, as rolipram pretreatment mimicked the 
effect of IBMX on potentiating the Fsk-induced response, in contrast to milrinone 
pretreatment (Fig 2.3a,b). Collectively, these data reveal differences in cAMP signaling 
within neuronal compartments and between HNs at different developmental stages. 
Specifically, both DIV3 and DIV5 HNs displayed higher AC activity towards the axon, yet 








whisker plots, with the box showing the median, 25% quartile, and 75% quartile, and the 
whiskers designating the 5th and 95th percentiles; a “+” indicates the mean. 
 
Because cAMP binds to PKA with an ~1000 fold higher affinity compared with 
Epac140, we suspected that the saturating effect of 50 µM Fsk stimulation was masking the 
underlying spatial differences in PKA activity. We therefore tested whether submaximal 
stimulation would reveal a PKA gradient. Indeed, treating DIV5 cells with tenfold less 
(500 nM) Fsk generated an axon-directed PKA activity gradient that paralleled the cAMP 
response (Fig. 2.6a,b; left). On the other hand, DIV3 cells showed only small (~5%) 
responses to the low dose of Fsk, with no significant differences between the regions (Fig. 
2.6a,b; right). Pretreating DIV3 HNs with IBMX resulted in an ~40% ratio increase in 
response to 500 nM Fsk, whereas IBMX treatment alone produced an ~50% ratio increase 







and the whiskers designating the 5th and 95th percentiles; a “+” indicates the mean. ns, not 
significant. 
 
We also observed a clear, axon directed gradient in the AKAR4 starting ratio in 
DIV5 HNs (Fig. 2.7). Although control cells expressing AKAR4-TA also exhibited higher 
starting ratios in the distal axon, possibly due to slightly higher levels of the probe in this 
region, the starting ratio differences were steeper with AKAR4 than with AKAR4-TA in 
DIV5 HNs (Fig 2.7), whereas both AKAR4 and AKAR4-TA exhibited similar starting 
ratio differences in DIV3 HNs (Fig. 2.7), suggesting the presence of a bona fide gradient 
of basal PKA activity in resting DIV5 HNs. These data indicate that PKA follows the 
cAMP response pattern seen in DIV5 HNs, with an axon-directed gradient of PKA activity, 






AKAP-Lbc132, 141 that is known to disrupt PKA RII binding to AKAPs. In DIV5 HNs, st-
Ht31 treatment led to a minimal change in the PKA activity within the somatodendritic 
compartment and a larger decrease in the axonal regions (Fig. 2.8a,b; left). On the other 
hand, DIV3 HNs exhibited no significant change in PKA activity among the different 
regions (Fig. 2.8a,b; right) following st-Ht31 treatment. DIV5 HNs transfected with the 
negative-control reporter exhibited no change upon st-Ht31 treatment (Fig. 2.9). These 
results further support our conclusion that the starting ratio differences in DIV5 HNs 
correspond to differential PKA activity and reveal that the axonal PKA gradient is 






AKAP-PKA anchoring and then performed immunostaining to detect Tau1, an axon-
specific marker, as well as MAP2, a dendrite specific marker, after 72 h in vitro (DIV3) 
(Fig. 2.10). Axon growth was assessed by measuring the length of the longest Tau1-
positive neurite extending from the soma of each cell. Based on the reported positive role 
of PKA in axon development, we expected the disruption of PKA anchoring to have a 
detrimental effect on axon outgrowth. Surprisingly, however, we observed significantly 
longer neurites in DIV3 HNs treated with st-Ht31 compared with control HNs treated with 
DMSO, and treatment with a scrambled peptide (st-Ht31p) had no effect on neurite length 
(Fig. 2.10b-d,i). Furthermore, PKA inhibition by either H89, KT5720, or Rp-8-Br-
cAMPShad no effect on axon elongation (Fig. 2.10e-g,i). The enhancement of neurite 
outgrowth with st-Ht31 was also dose dependent, with increasing doses of st-Ht31 






Disrupting AKAP-PKA anchoring enhances the cAMP gradient in DIV3 hippocampal 
neurons 
Combined with our previous observation that axonal PKA activity is supported by 
AKAP anchoring, the fact that disrupting the PKA-AKAP microdomain enhances axon 
elongation suggests that AKAP-anchored PKA acts to limit axon elongation during early 
developmental timepoints. These results are surprising because cAMP and PKA are 
thought to promote axon polarization and elongation and because AKAP anchoring helps 
support PKA function. We therefore investigated whether the st-Ht31 effect on axon length 
was related to the observed spatial differences in cAMP signaling. To this end, we treated 
ICUE3-expressing DIV3 HNs with st-Ht31 followed by Fsk. The addition of st-Ht31 
yielded small increases in cAMP levels, with a slightly larger increase in the axon, and 
subsequent stimulation with Fsk produced a steep, axon-directed cAMP gradient (Fig. 
2.12a-c). Comparing the Fsk-induced ICUE3 response in DIV3 HNs with and without st-
Ht31 pretreatment revealed a significant difference in cAMP levels in the distal axon (Fig. 
2.12d). In fact, this gradient was very similar to that observed in DIV5 HNs treated with 
Fsk alone (Fig. 2.1 and Fig. 2.12e). These data imply that delocalizing PKA from the 
AKAP microdomain actually enhances cAMP accumulation in DIV3 HNs, especially in 
distal regions of the axon. Hence, younger neurons with delocalized PKA exhibited cAMP 







and limits axon elongation. Disrupting this AKAP-anchored feedback circuit leads younger 
cells to mimic more mature (e.g., DIV5) HNs, in which the feedback circuit is absent, by 
prematurely forming an axon-directed cAMP gradient that drives axon elongation. 
 
Figure 2.15. Model of compartmentalized cAMP signaling in developing HNs. 
At early stages of growth (DIV3, left), PDEs have high activity, and the neuron exhibits a 
shallow gradient of cAMP from the distal axon to the somatodendritic region. The PDE 
activity in the soma of a DIV3 cell keeps [cAMP] low, while AKAP-mediated PKA-to-
PDE feedback dampens [cAMP] in the distal axon, thereby restraining axon outgrowth. At 
later stages of growth (DIV5, right), high PDE activity keeps [cAMP] low in the soma, 
while the absence of PKA-mediated negative feedback in the axon enables the formation 
of a steep [cAMP] gradient, with the highest [cAMP] in the distal axon, leading to the 
activation of downstream effectors such as Epac and PKA, which regulate axon growth. 






cAMP/PKA signaling is essential to neuronal development and growth. Some of 
the earliest studies on the role of cAMP in axon biology focused on axon guidance, 
indicating that local sources of cAMP can act as attractants for growth cones136, 145. Recent 
work on axon formation also showed that neurons prefer to grow axons on cAMP-laden 
stripes and are repelled by stripes containing inhibitory cAMP analogs or PKA inhibitors70, 
while individual neurites exposed to a local source of cAMP tended to turn into axons 
rather than dendrites. Our investigation revealed growth stage-specific cAMP gradients 
and suggests that a steeper cAMP gradient is correlated with enhanced axon elongation. 
These findings are in keeping with past observations of spatially regulated cAMP signaling 
during axon development, such as local elevations in cAMP within the growth cones of 
Xenopus spinal neurons146. Although local signaling events can often be driven by the 
spatial distribution of signaling factors such as ACs128, our analyses did not reveal any clear 
spatial differences in the distribution of AC or PDEs in either DIV3 or DIV5 HNs that 













Figure 2.20. Expression of cAMP effectors in hippocampal neurons. 
(d) Immunostaining for Epac1 and Tau1 in DIV5 (top) and DIV3 (bottom) HNs. Left, Tau1 
(axon marker, magenta); middle, Epac1 (cyan); right, overlay. Scale bar, 50 µm. 
 
The effects of delocalizing PKA using st-Ht31 specifically highlight the importance 
of AKAP-compartmentalized PKA activity in developing HNs, and are consistent with 
previous findings of PKA compartmentalization within specific neuronal structures151. 
AKAPs often act to facilitate PKA signaling by colocalizing PKA with downstream 
targets129 32 and by coupling PKA activity to specific upstream signals152. However, AKAP 
anchoring can also play a major role in shaping the dynamics of both PKA and cAMP 
signaling by localizing PKA with regulatory proteins such as PDEs153,154, and our results 
indicate that this type of “regulatory” AKAP microdomain is central to directing the course 
of axon elongation in developing HNs. For instance, AKAP12/Gravin, which binds both 
PKA and PDE4D, can be found throughout mouse HNs155 and in punctate structures in 
NT2-N human model neurons156. Another PKA/PDE4D3 scaffold, AKAP9 can assemble 
signaling platforms on centrosomes, and its splice variant Yotiao has also been shown to 
bind NMDA subunits157, although Yotiao has not been shown to bind to PDEs. 
Interestingly, WAVE-1 knockout mice exhibit clear changes in brain structure and 
behavioral deficits158, and knocking down WAVE-1 in HNs reduces axon length159; 
however, WAVE-1 has also not been demonstrated to bind PDEs. Lastly, mAKAP, which 
binds Epac1, PKA, PDE4D3 and ACs, has been found to promote axon elongation and 
survival in injured retinal ganglion cells, but not during normal growth160. Nevertheless, 
the mAKAP signalosome may also play a role in coordinating cAMP signaling in different 
neuronal cell types, including HNs. However, while we were able to detect the expression 







of axonal development and demonstrates that PKA plays a much more complex role in 
neuronal development than was previously known. Precise spatial control can therefore 
allow a signaling molecule to play seemingly opposite functional roles in the same cell.  
 
Materials and Methods 
Reagents 
Papain Dissociation System was purchased from Worthington (Lakewood, NJ). 
Neurobasal was purchased from Invitrogen (21103-049). B27 was purchased from Gibco 
(17504044). Pen-Strep was purchased from Thermo-Fisher (15140122). GlutaMax was 
purchased from Gibco (35050061). Poly-D-Lysine (PDL) was purchased from Sigma 
(P6407). Lipofectamine LTX was purchased from Invitrogen (15338030). Forskolin (Fsk, 
344270) and 3-isobutyl-1-methylxanthine (IBMX, 410957) were purchased from 
Calbiochem and used at a final concentration of 500 nM or 50 µM (Fsk) and 100 µM 
(IBMX)161 162, 163. H89 was purchased from Sigma (B1427) and used at a concentration of 
10 µM81, 164. KT5720 (K7361), Rp-8-Br-cAMPS(B1381), and ESI-09 (SML0814) were 
purchased from Sigma. St-Ht31 (V8211) and st-Ht31p (V8221) were purchased from 
Promega. Paraformaldehyde solution (16%) was purchased from Electron Microscopy 
Sciences (15700, 4% final dilution). Rabbit anti-Tau1 (ab64193, 1:100 dilution) and 
mouse anti-NST (ab14545, 1:1000 dilution) were purchased from Abcam. Mouse-anti 
MAP2 (1:500, MAB3418) was purchased from Millipore. Rabbit anti-AKAP79 (1:100, 
sc10764), rabbit anti-AKAP95 (1:100, sc10766), rabbit anti-PDE3B (1:100, sc-20793), 
rabbit anti-PDE4D (1:100, sc-25814) and mouse anti-Epac (1:100, sc-28366) were 




was purchased from Novus Biological. Mouse anti-WAVE 1 (1:100, ab106516) and 
rabbit anti-ADCY5/6 (1:100, ab196748) were purchased from Abcam. Rabbit anti-PKA 
(Cα) (1:100, ab4782) was purchased from Cell Signaling Technologies. Mouse anti-PKA 
RIIβ (1:100, 610625) and mouse anti-PKA RIα (1:100, 610165) were purchased from BD 
Biosciences. Goat anti-mouse Alexa-Fluor 488 (A-11001, 1:1000 dilution) and goat anti-
rabbit Alex-Fluor 568 (A-11036, 1:1000 dilution) were purchased from ThermoFisher 
Scientific. Prolong Gold antifade mounting reagent was purchased from Life 
Technologies (P36930).  
Cell Culture 
Primary rat hippocampal neurons - Hippocampi were dissected from E18 Sprague 
Dawley rat (Rattus norvegicus) pups (Harlan, Indianapolis, IN) in ice-cold Hank’s 
Balanced Salt Solution (HBSS) supplemented with 20 mM HEPES, pH 7.4, 5 mM D-
glucose, 0.23 mM sodium pyruvate, and 0.5% pen-strep and were dissociated using the 
Papain Dissociation System according the manufacturer’s instructions. Dissociated HNs 
were re-suspended in Neurobasal medium supplemented with 2.0% B27 supplement, 0.5% 
pen-strep and 2.0 mM Glutamax. Each separate preparation contained pooled tissues from 
a single litter (~10-12 pups), with one preparation performed per week. Approximately 
1.0x105 cells were plated onto 35-mm nitric acid-treated glass-bottom imaging dishes 
coated with 150 µg/mL PDL. Cells were given a 50% media change every three days to 
restore glucose levels to 3.0 mM as previously described165. Cells were cultured at 37°C in 
a humidified incubator at 5% CO2. At DIV2 or DIV4, cells were transfected with 





Cells were washed twice with HBSS prior to imaging and maintained in the dark at 
37°C. DMSO, Fsk, IBMX, H89 and st-Ht31 were added as indicated. Dual emission ratio 
imaging was performed on a Zeiss AxioObserver Z1 microscope (Carl Zeiss, Thornwood, 
NY) equipped with a 40x/1.3 NA objective and a Photometrics Evolve 512 EMCCD 
(Photometrics, Tucson, AZ) controlled by METAFLUOR 7.7 software (Molecular 
Devices, Sunnyvale, CA). Images were acquired using a 420DF20 excitation filter, a 
450DRLP dichroic mirror, and two emission filters (475DF40 for CFP and 535DF25 for 
YFP) alternated by a Lambda 10-2 filter-changer (Sutter Instruments, Novato, CA). 
Exposure times ranged between 50 and 500 ms, and images were acquired every 30 s. 
Images were analyzed in METAFLUOR 7.7 by defining a single region of interest (ROI) 
for the dendrites and for the soma, with the axon separated into three equal-length ROIs of 
~40-50 µm (Fig. 2.22). The proximal axon region is defined as the length of axon extending 
directly from the soma, and the middle and distal axon regions correspond the next two 
equal-length segments after the proximal segment. The same axon segments were analyzed 





immediately before drug addition. Pseudocolor ratiometric images were scaled to the 
indicated upper and lower bounds for emission ratios. In some cases, the cell body of the 
neuron is brighter than the rest of the cell and therefore appears black or pink. The color of 
the soma is not an indication of intensity saturation. The pseudocolor images were not used 
for data analysis. 
Immunocytochemistry 
Approximately 2.0x104 HNs were cultured on nitric acid-washed, PDL-coated 15-
mm glass coverslips for ~16-20 h, treated with the indicated drugs, and cultured for an 
additional 48 h. At DIV3, cells were fixed with 4% PFA for 20 min at room temperature. 
Free PFA was quenched with 100 mM glycine in HBSS. Cells were then permeabilized 
and preincubated in blocking buffer (5% goat serum, 0.2% BSA, 0.1% Triton-X 100, and 
0.01% NaN3 in HBSS) for 30 min. The cells were incubated overnight at 4°C with the 
following primary antibodies in blocking buffer: rabbit Tau1 and mouse NST. On the 
following day, the cells were washed 3 times in HBSS and incubated with goat anti-rabbit 
Alexa-Fluor-568 or goat anti-mouse Alexa-Flour-488 secondary antibody for 2 h at room 
temperature in the dark. Cells were then washed once with HBSS, counterstained with 1 
mg/mL Hoechst stain to visualize the nuclei, and washed another 3 times with HBSS. 
Prolong Gold anti-fade mounting reagent was used to mount coverslips for imaging on a 
Zeiss LSM700 inverted confocal microscope (Zeiss, Oberkochen, Germany). All image 






Graphs were plotted using GraphPad Prism 6 (GraphPad, La Jolla, CA), and all 
statistical analyses were performed using the same software. Sample size was not 
predetermined prior to performing the experiments, Cells were excluded from data 
acquisition when axons and dendrites were not obviously developed. Pairwise comparisons 
were performed using two-sided Student’s t-test, and statistical significance was set at 
p<0.05. Global comparisons of sensor responses were performed using one- or two-way 
ordinary ANOVA analysis, and statistical significance was set at p<0.05. Bar graphs depict 
the mean±S.E.M. For box-and-whisker plots, the box shows the median, 25% quartile, and 
75% quartile, and the whiskers designating the 5th and 95th percentiles; the mean value is 












































 Compartmentalization of cellular signaling allows cells to control a signal’s 
specificity, duration, and magnitude167. One method a cell uses to compartmentalize signals 
is by organizing signaling components into discrete signaling microdomains168. Examples 
of discrete subcellular locations are the surfaces of organelles like the plasma membrane 
(PM) rafts, and non-raft PM regions, nucleus, mitochondria, and endoplasmic reticulum 
(ER). Each of these locations and organelles have unique profiles of different signaling 
pathways, which endow them with specialized function. For example, the membrane rafts 
are small, rigid platforms made up of cholesterol and glycosphingolipids, which serve as 
organizing centers for membrane components such as receptors, ion channels, and other 
enzymes to regulate signaling pathways169.  
 The cyclic guanosine monophosphate (cGMP) signaling pathway is found in all 
organisms from bacteria to humans. Some of its many functions includes regulating gene 
expression170, cell proliferation171, 172, and cell metabolism173. Specialized cells like 
cardiomyocytes utilize cGMP for proper ventricular function in the heart. Smooth muscle 
cells use cGMP to relax blood vessels, and neurons use cGMP signaling in differentiation 
and development. cGMP is produced by enzymes that catalyze the conversion of GTP in a 
cyclization reaction to generate cGMP. In rod photoreceptors, a high cGMP concentration 
activates cGMP-gated sodium channels, which keeps cells depolarized in the dark174, 175. 
In cortical neurons, dendrite outgrowth stimulated by Semaphorin3A was mediated by 
increases in cGMP99. Sema3a simultaneously suppresses axon outgrowth via the mutual 
inhibition of cAMP leading to reduced PKA activity, which inhibits LKB1, activates 
GSK3β, and prevents axon polarization. This study highlights the important interplay 




Soluble guanylyl cyclases are found throughout the cell and are stimulated by nitric oxide 
(NO) while particulate guanylyl cyclases are transmembrane receptors for natriuretic 
peptides like ANP176. cGMP is regulated by the enzymatic activity of phosphodiesterases 
(PDEs) that catalyze its hydrolysis and prevent saturation of the cell with the second 
messenger. Understanding how cGMP signals are distributed within living cells in space 
and time helps researchers connect signaling responses to specific biological outcomes.  
 Traditional methods of studying biochemical activity are insufficient to provide a 
high resolution map of spatiotemporal signaling dynamics in living cells. Fluorescence 
resonance energy transfer (FRET) biosensors are well suited to provide such information 
with using a ratiometric fluorescence intensity readout135. These powerful probes can be 
used to visualize molecular activity with high spatial and temporal resolution in real time 
in living cells. Nikolaev et al. have constructed FRET-based cGMP biosensors using the 
cyclic nucleotide binding domain (CNBD) GAF-A from PDE5A as the sensing unit 
sandwiched between the reporting unit fluorescent protein donor ECFP and acceptor 
EYFP117. When cGMP binds to the sensing unit, it induces a conformational change and 
increases FRET in the reporting unit. To better understand compartmentalized cGMP 
signaling, we targeted the cGMP energy transfer sensor derived from PDE5A (cGES-DE5) 
to multiple locations within the cell using localization sequences to deliver the reporter to 
the proper subcellular compartment. We found that cGMP dynamics are differentially 






Generation and expression of organelle specific cGMP reporters 
We first constructed the genetically encoded FRET-based cGMP biosensor cGES-
DE5 (Fig. 3.1a) by cloning the GAF-A domain from PDE5A and inserting it between 
ECFP and EYFP in cGES-DE2, another cGMP reporter generated by Nikolaev et al.117. 
In this sensor, the binding of cGMP results in a conformational change in the PDE5A 
GAF-A domain and an increase in the acceptor-to-donor (Y/C) emission ratio. Using this 
probe, we observed emission ratio increases (Fig 3.1b) in Cos-7 cells treated with 80 µM 
sodium nitroprusside (SNP), a nitric oxide donor and general activator of soluble ACs, 
which confirmed SNP can elevate cGMP levels inside Cos-7 cells177. The normal, 
unmodified reporter has a diffuse localization when expressed in Cos-7 cells. We 
appended signal sequences to cGES-DE5 in order to localize the sensor to different 
subcellular compartments including the general PM, membrane rafts, the nucleus, 
mitochondria, and the ER (Fig. 3.1c-h). The PM localized reporters were constructed 
using lipid modification domains. The non-membrane raft PM targeted reporter cGES-
DE5 K-Ras utilizes a CaaX (C = cysteine, a = aliphatic amino acid, and X = any amino 
acid) sequence combined with a stretch of lysine residues to anchor the reporter to the 
PM. The N-terminus of Lyn kinase tethers the Lyn cGES-DE5 reporter to the membrane 
rafts via myristoylation and palmitoylation114, 178. Nuclear targeting was achieved with a 
nuclear localization signal105. An N-terminal motif from DAKAP1a, a mitochondrial 
outer membrane protein, was used to generate mito cGES-DE5105, and an N-terminal 






Characterizing the sGC generated cGMP dynamics using os-cGES-DE5 reporters in 
Cos-7 cells 
The average SNP stimulated emission ratio change was significantly different 
between the whole cell, membrane rafts, general PM, and the nucleus (7.95±0.98%, 
4.96±0.65%, and 2.94±1.08% and 9.31±1.95% respectively, n=14≥ cells) (Fig. 3.2a), 
indicating that cGMP generated by the activation of sGCs is not uniform in all locations.  
Addition of IBMX to Cos-7 cells after treatment with SNP increased the emission ratio of 
each sensor to 22.14±2.08%, 18.07±1.36%, 11.64±2.53%, and 28.65±3.37% 
(mean±S.E.M.; n≥14) in the whole cell, membrane rafts, PM, and nucleus, respectively. 
These data are consistent with the known effects of PDE activity on cyclic nucleotide 
second messengers and further demonstrate the presence of this regulation in multiple 
cellular locations. To help characterize the sensors further, we calculated the SNP 
response as a percentage of the cumulative SNP + IBMX response. The data indicates 
that the compartment specific SNP response is not equal and further supports the idea that 
cGMP dynamics differ between subcellular compartments.  
 So far, we have shown that compartmentalized cGMP signaling stimulated by SNP 
is under the regulation of PDE activity. Inhibiting PDEs at the basal state can reveal the 
basal activity of sGC in the absence of any stimulation. Addition of IBMX to Cos-7 cells 
basally produced a minimal amount of cGMP indicating that sGC activity is generally low 
(Fig. 3.2c). As expected, subsequent addition of SNP produced a larger cGMP response 
than with SNP treatment alone. Interestingly, cGES-DE5 localized to the general PM 





Characterizing the pGC generated cGMP dynamics using os-cGES-DE5 reporters in 
HeLa cells 
 
 In cells, sGC and pGC are the cGMP generating enzymes stimulated by NO and 
natriuretic peptides like ANP, respectively.  Because we are interested in the 
compartmentalization of cGMP signaling, and cGMP enzymes are differentially localized 
in the cell, we tested the stimulation of NPR1, the receptor for ANP, in Cos-7 cells and the 
associated cGMP responses. Surprisingly, we were not able to see a significant cGMP 
response with any of our os-cGES-DE5 reporters (data not shown). We therefore used the 
HeLa cell line that has been reported to produce cGMP in response to ANP stimulation. 
HeLa cells expressing the os-cGES-DE5 reporters treated with 10 µM ANP responded with 
emission ratio increases of 10.0±3.55% (diffusible, n=10), 5.02±1.69% (membrane raft, 
n=15), 6.21±2.21% (PM, n=26), and 6.14±1.99% (nucleus, n=18) (Fig. 3.3a). Subsequent 
stimulation with 100 µM IBMX increased the response by ~10% in each region. The 
cumulative ANP + IBMX response was not significantly different between the regions. 
These data indicate that the os-cGES-DE5 sensors can detect ANP stimulated cGMP 
responses and that PDE activity controls the magnitude of cGMP increase in HeLa cells. 
By calculating the ANP response as a percentage of the cumulative ANP + IBMX response, 
we show that the diffusible reporter generated the largest ANP response while the 
membrane raft targeted reporter generated the smallest ANP response. The data indicates 
that similar to the SNP response in Cos-7 cells, the ANP stimulated pGC activity is 
compartmentalized. Interestingly, although pGCs are known to localize to the PM, we 
detected a large increase in the nucleus, which may support fast cGMP diffusion into the 





(a) Average responses represented as stacked bars to 10 µM ANP (white) and 100 µM 
IBMX (gray) in HeLa cells expressing cGES-DE5 localized to the general cell, membrane 
rafts, PM, and nucleus localized versions. Data shown as mean ±S.E.M. ns, not significant 
according to one-way ANOVA. (b) Average ANP responses as a percent of the cumulative 
SNP + IBMX response. (c) Average responses to 100 µM IBMX (gray) followed by 10 
µM ANP (white) in Cos-7 cells expressing cGES-DE5 localized to the general cell, 
membrane rafts, PM, and nucleus localized versions. Data shown as mean ±S.E.M. ns, not 
significant according to one-way ANOVA. 
 
Membrane raft disruption affects the cGMP levels produced by SNP stimulated sGCs in 
Cos-7 cells 
 cGMP signal regulation is achieved by compartmentalization of signaling 
components including receptors, regulators and effectors into discrete subcellular 
compartments to enhance signal specificity. The PM microdomains called membrane rafts 
are rigid structures enriched in cholesterol and glycosphingolipids, which are known to 
compartmentalize cellular signaling components like the β2-adrenergic receptor for cAMP 
signaling. Cholesterol depletion by methyl-beta-cyclodextrin (MβCD) is a well-known 
method to disrupt membrane rafts regions of the PM and has been shown to modulate PM 
signaling dynamics114. We tested the SNP stimulated sGC responses in membrane raft and 
non-membrane raft microdomains in the presence of MβCD using Cos-7 cells expressing 
Lyn cGES-DE5 and cGES-DE5 K-Ras, respectively. Cells were pretreated with MβCD for 
one hour prior to stimulation with the cGMP agonists. We found that disruption of 
membrane rafts via cholesterol depletion significantly enhanced the SNP stimulated sGC 
response by ~10% in the membrane raft microdomain (Fig. 3.4a,b). MβCD significantly 
enhanced the non-membrane raft cGMP response to SNP by ~5% (Fig. 3.4c,d). Together, 






and 95th percentiles; a “+” indicates the mean. * indicates p<0.05, ns, not significant 




 Our study of compartmentalized cGMP signaling suggests that there are differences 
between subcellular compartments and sources of cGMP production and regulation. First, 
we observed significant location specific differences in cGMP signaling with SNP 
stimulation. As the sGC maintains a diffuse localization throughout the cell, the detection 
of different levels of cGMP activity support the hypothesis that cGMP signaling is 
differentially regulated within discrete compartments. In fact, the combined nuclear SNP 
and IBMX generated the largest dynamic range as compared to the other regions. 
Importantly, the presence of nuclear cGMP as reported by the cGES-DE5 NLS biosensor 
suggests either sGC is localized to the nucleus or cGMP is able to diffuse quickly from the 
cytoplasm to the nucleus. Secondly, PDE inhibition prior to SNP revealed low levels of 
basal sGC activity, whereas SNP stimulation in the presence of PDE inhibition generated 
a heightened SNP response, suggesting the elevation of cGMP is coupled to and regulated 
by PDE activity. The responses of the diffusible, raft, and non-raft reporters are also 
increased when PDEs are inhibited before the addition of SNP, suggesting that there is a 
temporal component to cGMP activity and that the sequence of activation plays a role in 
the magnitude of the cGMP response. During the SNP treatment, PDEs are activated and 
degrade the newly generated cGMP, effectively limiting the maximum concentration of 
cGMP to be produced. With PDE inhibition, the negative regulation is removed and the 
cell has a higher potential to generate cGMP. Future studies will examine the contribution 




 In our attempt to understand cGMP signal regulation by different mechanisms, we 
found that the cGMP response is cell type-dependent.  Here, we were not able to activate 
sGCs in HeLa cells, nor were we able to activate pGCs in Cos-7 cells. Therefore, we could 
not make direct comparisons between sGC and pGC regulation of cGMP levels in the same 
cell type. Nonetheless, we analyzed ANP stimulated cGMP responses in HeLa cells and 
found less variability in the compartmental responses. Still, HeLa cells exhibited a sizeable 
nuclear cGMP response to ANP. Under the assumption that pGCs are localized to the PM, 
the data suggests that cGMP is able to diffuse readily into the nucleus to activate any 
potential effectors that may reside there. The negative regulation of cGMP by PDEs is a 
general rule and is exemplified by the heightened ANP response when PDEs are inhibited 
prior to stimulation with ANP.  
 Our results suggest that membrane rafts play a more important role in shaping the 
cGMP responses from sGCs than from pGCs. We observed an enhanced cGMP response 
to SNP in Cos-7 cells upon membrane raft disruption. Surprisingly, the response was 
increased in both the raft and non-raft compartment. The specific mechanism for the 
enhancement is unknown, but may be related to a redistribution of signaling components 
like PDEs or other cGMP binding partners. Alternatively, sGCs present within the raft 
regions may be under negative regulation and raft disruption releases the inhibition, 
effectively elevating the potential for sGCs to generate cGMP upon sensing NO.  
 This study emphasizes the importance of understanding how cellular microdomains 
regulate cGMP signaling dynamics. Further development of high-resolution, quantitative 
live-cell imaging techniques will play a critical role in assessing how compartmentalized 




to the field a suite of cGMP biosensors that can specifically detect free cGMP at specific 
organelles. This suite of sensors can be expanded to other locations like the lysosome and 
golgi, or more specifically, tethered to proteins to detect nanodomain pools of cGMP. os-
cGES-DE5 biosensors have allowed us to track subcellular cGMP signaling dynamics in 




 The cyclic nucleotide cGMP is a critical second messenger molecule responsible 
for initiating signaling cascades that regulate critical biological functions. It is well 
appreciated that spatiotemporal compartmentalization of cGMP allows for specific signal 
transduction through the generation of subcellular pools or microdomains of cGMP 
signaling. Given that there are two ways to generate cGMP inside of a cell, by activating 
pGCs or sGCs, it important to understand the spatiotemporal dynamics of cGMP in 
different subcellular compartments. Although several cGMP biosensors have been 
developed for detecting free cGMP in the entire cell, there are no biological tools available 
to study compartmentalized cGMP signaling within living cells in real time. To this end, 
we have generated a suite of cGMP sensors targeted to specific subcellular compartments 
using signal sequence targeting motifs. Here, we have characterized the sensors within 
membrane rafts in the PM, non-membrane rafts regions of the PM, and the nucleus. First, 
we tested the subcellular cGMP responses with sGC stimulation and pGC stimulation. 
Interestingly, we observed a lack of pGC stimulation in Cos-7 cells, and a lack of sGC 
stimulation in HeLa cells. In either cell type, we did not detect a significant difference in 




cholesterol depletion changes the sGC stimulated cGMP response indicating the integrity 
of membrane rafts shapes cGMP dynamics. This study demonstrates that 1) subcellular 
cGMP dynamics can be detected using FRET-based biosensors, 2) different cell types have 
different modes of cGMP signaling, and 3) cGMP signaling at the membrane is dependent 
on the integrity of membrane rafts.  
Signal transduction is the process that cells use to respond to their environment and 
adapt appropriately. Many of signaling pathways rely on second messengers like the cyclic 
nucleotides to convert the signal from outside to inside of the cell. Once a signal is 
converted, intracellular signaling mechanisms control the duration and intensity of the 
response. cGMP is one of the two cyclic nucleotides used for many critical cellular 
functions. Compartmentalization provides a cell with the ability to control the specificity 
and response of cellular signals. This work sought to understand how cGMP is regulated 
in discrete subcellular compartments by utilizing genetically encodable FRET-based 
biosensors for cGMP targeted to these signaling microdomains. Traditional techniques like 
western blot and immunoassays do not allow for visualization of signaling dynamics in 
living cells. The organelle-specific cGES-DE5 sensors overcome these limitations 
providing a real time ratiometric readout of cGMP signaling in specific locations within 
the cell. Here, we constructed targeted versions of the sensor using localization signals 
appended to the N- and C-termini of the reporter. We were able to show that subcellular 
cGMP activity is indeed different in different cells and confirmed the regulation of cGMP 
by phosphodiesterases. Altogether, our work introduces a method by which cGMP signals 
can be tracked in real-time within subcellular compartments of living cells. These sensors 




cGMP signaling pathway. Furthermore, understanding cGMP compartmentalization using 
these sensors would greatly benefit preclinical studies involving cardiac myocytes and 
neurons, which are heavily dependent on cGMP for their functions.  
 
Materials and Methods 
Generating os-cGES-DE5 constructs 
cGES-DE2 was a gift from the Nikolaev lab and was used as a template for 
cGES-DE5 created in our lab. The GAF-A domain was cloned from PDE5A using primer 
amplification and inserted into cGES-DE2 between ECFP and EYFP. cGES-DE5 was 
targeted to membrane rafts by a 5’ myristoylation and palmitoylation lipid modification 
sequence (GCIKSKRKDK) derived from Lyn kinase and to non-rafts by a 3’ 
farnesylation lipid modification sequence (KKKKKKSKTKCVIM) derived from K-Ras 
kinase. cGES-DE5 was targeted to the nucleus using a 3’ nuclear localization signal 
(PKKKRKVEDA). cGES-DE5 was targeted to the mitochondria using a 5’ targeting 
motif from DAKAP1a (MAIQLRSLFPLALPGMLALLGWWWFFSRKK). cGES-DE5 




Sodium Nitroprusside was purchased from Sigma. ANP was purchased from 
Sigma. 3-isobutyl-1-methylxanthine (IBMX, 410957) were purchased from Calbiochem 
and used at a final concentration of 100 µM (IBMX)161 162, 163. Methyl-β-cyclodextrin 






Cos-7 and HeLa cells were cultured in DMEM supplemented with 10% FBS and 
1% Pen-Strep and maintained at 37 °C with 5% CO2. For imaging, cells were plated onto 
sterilized glass cover slips in 35 mm dishes, transfected with Lipofectamine 2000 at 50-
60% confluency, and then grown for approximately 24 hours before imaging. 
 
Imaging 
Cells were washed twice with Hanks’ Balanced Salt Solution (HBSS) and imaged 
in the dark at room temperature. Cholesterol depletion experiments were carried out by 
treating cells with 4 mM methyl-β-cyclodextrin (MβCD; Sigma) for 30 minutes at 37 °C 
before imaging. Cells were treated with SNP, ANP, and IBMX as indicated in the graphs. 
Images were acquired on an Axiovert 200M microscope (Carl Zeiss, Thornwood, NY) with 
a cooled charge-coupled device camera (Roper Scientific, Trenton, NJ) controlled by 
Metafluor 6.2 software (Molecular Devices, Downingtown, PA). Dual emission ratio 
imaging used a 420DF20 excitation filter, a 450DRLP dichroic mirror, and two emission 
filters (475DF40 for CFP and 535DF25 for YFP). Exposure time was 50–500 ms and 
images were acquired every 30 s. Background correction of the fluorescence images was 
performed by subtracting autofluorescence intensities of untransfected cells or regions of 
the imaging dish with no cells. Graph curves were normalized by setting the emission ratio 



















Information from the external environment comes to cells in many forms and must 
be appropriately transduced by cells. From hormones and ions, to small molecules and 
neurotransmitters, proper conversion of extracellular signals to activate intracellular signal 
transduction pathways is essential for the proper functioning of cells. Different cell types 
utilize signal transduction pathways in different ways, but common to all cells is the 
requirement for appropriate regulation of signaling modules in both space and time. The 
spatiotemporal regulation of signaling networks is a complex process involving many 
players and signal transduction events. For cyclic nucleotides, the spatiotemporal 
compartmentalization is achieved by several methods including physical segregation of 
enzymes like GPCRs, cyclases, and phosphodiesterases and the activity of these enzymes 
and cyclic nucleotide effectors helps generate specific cellular responses. Understanding 
these spatiotemporal dynamics helps us understand where and when a signal is acting, 
allowing researchers to connect the cellular signals to cellular functions. Studies on signal 
transduction networks from living cells provide the most relevant information, as the native 
biological context of the cellular milieu in live cells permits researchers to study the signal 
transduction pathways as they occur in nature, rather than reconstituting the pathway 
components in vitro. Here, we have shown how FRET-based biosensors expressed in 
primary neuronal cells and heterologous cell lines can be used as biological tools to study 
the spatiotemporal dynamics of cyclic nucleotide signaling. 
 In primary hippocampal neurons, we have used cAMP and PKA biosensors 
to reveal the gradients of molecular activity in the developing axon which have long been 
alluded to in the literature as playing an important role in the function of cAMP/PKA 




highlights their role in axon development. We further dissected how PDEs regulate these 
gradients and by using PDE isoform specific inhibitors showed that PDE4, not PDE3, is a 
major regulator of cAMP in developing neurons. While our investigation into the 
regulation of cAMP gradients by PKA, AKAPs, and PDEs revealed a new and unexpected 
mechanism for controlling axon outgrowth in developing hippocampal neurons, it raises 
the question of how enhanced cAMP gradients in the axon can drive elongation. It is now 
well-appreciated that the cAMP effectors Epac1 and PKA both play important roles in axon 
development. It would therefore be interesting to understand the activity dynamics of Epac 
itself within the axon and how PKA and Epac interact within AKAP signaling 
microdomains to engage in axon elongation. Our work also brings AKAPs into the fold of 
neuronal differentiation and development. While AKAPs have been studied in the context 
of neuronal excitation and action potentials, researchers have not yet included AKAPs into 
the discussion of nervous system development. Our work lays the foundation for studying 
AKAPs in this new context and identifying which AKAPs are most important in the 
developing axon.  
 The second study presented here introduces FRET-based biosensors for the 
study of compartmentalized cGMP signaling which up until this point have not been 
available. We have designed subcellularly targeted biosensors to sensitively monitor 
cGMP dynamics with high spatiotemporal resolution. With these tools researchers are now 
able to study how localized cGMP signaling varies with disease and therapeutic treatment.  
 The importance of proper signal regulation in cells has been heavily 
emphasized throughout this work. To achieve specific cellular responses, signals must be 




cGMP signaling pathways mean that dysregulation may lead to improper signal 
transduction; a consequence that may lead to diseased states. The implications of the basic 
science research presented herein are two-fold: it provides a foundation for future research 
projects in understanding how cAMP/PKA signaling contributes to the development of the 
nervous system and delivers tools to further characterize compartmentalized cGMP 
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The Liver Kinase B1 (LKB1) is a heterotrimeric protein consisting of LKB1 and 
cofactors STRAD-α and MO-25179. LKB1, a bonafide tumor suppressor, is a master kinase 
of 13 kinases of the AMPK subfamily including BRSK1/2, AMPK, NUAK, SIK, and 
MARK180-182. LKB1 is activated by cofactor binding and recruitment out of the nucleus183. 
It is considered to be constitutively active; any endogenous agonists or antagonists that 
directly bind to LKB1 have yet to be identified. However, regulation by posttranslational 
modifications have been described. For instance, PKA phosphorylation of Ser431 on 
LKB1’s C-terminal tail increases LKB1 dependent phosphorylation of the AMP-activated 
protein kinase (AMPK)184, however this point of LKB1 regulation is controversial185. 
LKB1’s role in cell polarity has been well documented in cortical neurons in vitro94 and in 
vivo31 and drosophila epithelium. Loss of LKB1 activity by mutating Ser431 or transgenic 
knockout prevents axon initiation and neuronal polarization in cortical neurons93. 
Currently, there is only one way to pharmacologically inhibit LKB1 function. Developed 
by Mellman et al., an analogue sensitive kinase allele by mutating the “gatekeeper” Met 
129 to Gly makes LKB1 sensitive to inhibition by the small molecule 1-NM-PP1186. 
Despite this development, studying LKB1 activity dynamics has been a challenge due to a 
lack of tools to perturb LKB1 function. Given that LKB1 is a critical player in axon 
initiation, it is important to understand LKB1 dynamics in living cells. To this end, we have 
been developing a genetically encoded LKB1 substrate peptide to use as a competitive 
inhibitor in living cells.  
This approach was successfully demonstrated for AMPK by Miyamoto et al. who 
successfully constructed an AMPK substrate based inhibitor peptide called AMPK 




phosphorylation efficiency for SIK, NUAK, BRSK1/2, and AMPK180. For our first 
attempt, we have utilized the AMPK T-loop phosphorylated by LKB1 to generate an LKB1 
inhibitor peptide (LIP). For LKB1 studies, HeLa cells are an appropriate choice as they do 
not express LKB1 endogenously and are a natural control for LKB1 overexpression 
experiments179, 188.  
Results 
Our assay for LKB1 activity consists of the coexpressing the AMPK and BRSK 
activity reporter (ABKAR)189 (Fig. 4a) with either LKB1 or LKB1 and a fusion protein 
consisting of mCherry, FKBP, and LIP (mChF-LIP) in HeLa cells (Fig. 4.1a). The mCherry 
is a fluorescent protein tag and allows us to detect expression, while the FKBP increases 
the versatility of the tool for future applications involving FRB-FKBP chemically induced 
dimerization187. In this assay, we are using AMPK activity and the ABKAR FRET response 
as a proxy for LKB1 activity. If LKB1 activity is high, we should see a relatively high 
FRET ratio in cells expressing LKB1 compared to those not expressing LKB1. When 
mChF-LIP is coexpressed with ABKAR and LKB1, we would expect a lower FRET ratio 
as LKB1 phosphorylation of the reporter would be competitively inhibited by mChF-LIP.  
We first observed the ABKAR starting ratio (SR) to assess basal activity of AMPK 
and therefore LKB1. Cells expressing ABKAR alone had an average SR of 0.98±0.032% 
(mean±S.E.M, n=14) (Fig. 4.1b). The SR of cells co-expressing ABKAR and LKB1 was 
0.93±0.022% (mean±S.E.M, n=11) and was not significantly different than ABKAR-only 
expressing cells. Interestingly, the SR of cells co-expressing ABKAR, LKB1, and mChF-
LIP was significantly lower than ABKAR + LKB1 at 0.87±0.0061% (mean±S.E.M, n=19). 




of ABKAR. Therefore, we cannot conclude that mChF-LIP decreased the basal activity of 
LKB1.  
Next, we observed the normalized emission ratio changes under stimulated 
conditions. 2-deoxyglucose (2-DG) inhibits glucose metabolism and lowers ATP 
concentrations inside of the cell190. AMPK activity depends on phosphorylation of the 
T172 residue in the T-loop by LKB1 or CAMKK and increases in the AMP:ATP ratio. 
Stimulation of HeLa cells expressing ABKAR with 20 mM 2-DG increased the FRET ratio 
by only 2.60±1.18% (mean±S.E.M, n=14) (Fig. 4.1b,c). Cells expressing ABKAR + LKB1 
responded with a significantly greater FRET ratio increase of 23.91±2.70% (mean±S.E.M, 
n=11). Coexpression with mChF-LIP decreased the FRET response to 18.06±1.99% 
(mean±S.E.M, n=19). However, this diminished FRET response was not statistically 
significant.  
Finally, we tested mChF-LIP inhibition of LKB1 activity using western blot for p-
AMPK T172, the amino acid residue phosphorylated by LKB1. An analysis of normalized 
relative density of p-AMPK to total AMPK revealed an ~50% decrease in AMPK 





percentiles; a “+” indicates the mean. * = p<0.05, ns, not significant according to Student’s 
t-test. 
 
These preliminary analyses indicate that mChF-LIP may indeed be competitively 
inhibiting LKB1 activity. More imaging and biochemical studies need to be done to further 
confirm this inhibitory effect. The dual phosphorylation of AMPK T172 by LKB1 and 
CAMKK complicates this approach in a similar way to the development of the AMPK 
activity reporter189. Future studies will require confirmation that LKB1 inhibition by 
mChF-LIP is independent of inhibitory activity on CAMKK.  
To see if mChF-LKB1 was able to perturb any biological functions, we turned to 
the established role of LKB1 in initiating axon outgrowth in cortical neurons within the 
developing brain. PKA phosphorylation of LKB1 at Ser431 was shown to be critical for 
axon initiation in in vivo mouse studies94. To test if mChF-LIP could prevent axons from 
growing out of migrating cortical neurons, we in utero electroporated the following 
constructs into E15.5 embryos, pCAG-LSL-GFP (2ug/ul), pCAG-Cre (2ng/ul), and pCAG-
LSL-mChF or pCAG-LSL-mChFLIP (1ug/ul)191. This technique allows us to target the 
DNA constructs to specific brain regions, while Cre-dependent recombination and a low 
concentration of Cre DNA allows for clear identification of individual cells. We harvested 
the embryos at E18.5, took 250 µm sections of the brains and immunostained with the 
following primary antibodies: chicken anti-GFP (AVES) 1:1000, rabbit anti-DsRed 
(Living Colors) 1:1000, and mouse anti-Tau1 (Chemicon) 1:1000; and the following 
secondary antibodies DAPI 1:3000 (molecular probes), goat anti-chicken Alexa488 
(molecular probes) 1:1000, goat anti-rabbit Alexa555 (molecular probes) 1:1000, and goat 




A preliminary analysis of axon outgrowth revealed that brain slices expressing 
mChF-LIP (Fig. 4.2b-d) had more cells without axons (13.2±4.4, n=5 brains) than those 
expressing mChF (5.00±2.19, n= 5 brains) (Fig. 4.2a,c,d). This observation is consistent 
with the previous data indicating mChF-LIP can inhibit LKB1 activity and produce 
biologically relevant effects. However, brain slices expressing mChF-LIP also contained 
more cells with axons. To normalize these values, we calculated an axon outgrowth index 
(AOI) by dividing the total number of cells with axons by the total number of cells without 
axons. A larger AOI index indicates more axon outgrowth. mChF produced an AOI of 4.73 
compared to mChF-LIP, which had an AOI of 2.46. This data suggests mChF-LIP does 
indeed inhibit LKB1’s ability to initiate axon outgrowth from cortical neurons in the 
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